Janney Montgomery Scott LLC Has $7.61 Million Position in Chemed Co. (NYSE:CHE)

Janney Montgomery Scott LLC lifted its holdings in Chemed Co. (NYSE:CHE - Free Report) by 12.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,660 shares of the company's stock after purchasing an additional 1,425 shares during the quarter. Janney Montgomery Scott LLC owned 0.08% of Chemed worth $7,608,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. GAMMA Investing LLC raised its stake in shares of Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company's stock worth $47,000 after purchasing an additional 22 shares in the last quarter. American National Bank & Trust bought a new stake in Chemed during the third quarter worth $61,000. EntryPoint Capital LLC lifted its stake in Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company's stock valued at $94,000 after acquiring an additional 18 shares during the last quarter. Mather Group LLC. grew its position in shares of Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company's stock valued at $99,000 after acquiring an additional 69 shares during the period. Finally, Quarry LP grew its position in shares of Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company's stock valued at $103,000 after acquiring an additional 166 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada dropped their target price on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares of the company's stock, valued at approximately $62,117,555.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares in the company, valued at approximately $62,117,555.35. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director George J. Walsh III sold 200 shares of the business's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares of the company's stock, valued at approximately $1,991,615.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,144 shares of company stock valued at $3,002,419. 3.32% of the stock is owned by insiders.

Chemed Price Performance

Chemed stock traded up $6.71 during mid-day trading on Friday, hitting $561.43. 37,303 shares of the company's stock traded hands, compared to its average volume of 85,782. The firm has a 50 day simple moving average of $582.73 and a two-hundred day simple moving average of $566.54. Chemed Co. has a fifty-two week low of $523.33 and a fifty-two week high of $654.62. The stock has a market cap of $8.45 billion, a price-to-earnings ratio of 28.03, a P/E/G ratio of 2.23 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.32 EPS. On average, research analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.